ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
0,45
0,00
( 0,00% )
Mis à jour : 01:00:00

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

Dernier
0,45
Prix Achat
0,00
Prix Vente
0,00
Volume échangé
0,00
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Clôture Veille
0,45
Ouverture
-
Dernière Transaction
(O)
Dernière heure de transaction
-
Volume moyen (3 m)
-
Volume financier
-
VWAP
-

FRX Dernières nouvelles

Four Studies Published in The Lancet Show roflumilast (Daxas(R)), a New Oral Approach to COPD, Improves Lung Function and Reduce

-- Once-a-day tablet Daxas(R) (roflumilast) is a first-in-class treatment under development targeting inflammation, the underlying cause of chronic obstructive pulmonary disease (COPD) ZURICH...

Nycomed and Forest Laboratories to Collaborate on US Commercialisation of Daxas(R) in COPD

NEW YORK, Aug. 10 /PRNewswire-FirstCall/ -- -- Forest Laboratories acquires exclusive commercialisation rights to Daxas in the United States in treatment of symptomatic COPD -- Nycomed...

Beacon Equity Research on Stocks to Watch: Forest Labs, Harris, Philip Morris, IAMGOLD, Steel Dynamics and Wyndham

DALLAS, June 22 /PRNewswire/ -- BeaconEquity.com announces the availability of stock alerts on today's active stocks. Stock alerts highlight recent news, trading activity and relevant market...

Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic f

Data Presented at the 2008 International Conference of the American Thoracic Society TORONTO, May 20 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. and Laboratorios Almirall, S.A. today...

Milnacipran Demonstrated Significant Improvement in Pain and the Core Symptoms of Fibromyalgia Syndrome, Data Show

NEW YORK, Nov. 8 /PRNewswire/ -- Total daily dosages of milnacipran 100 mg and 200 mg demonstrated statistically significant and clinically meaningful improvements in both pain and other core...

Response Submitted to FDA Approvable Letter for Hypertension Compound Nebivolol

NEW YORK, May 1 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYSE: FRX) announced today that its licensing partner Mylan Laboratories (NYSE:MYL) submitted a response to the approvable...

/C O R R E C T I O N -- Forest Laboratories, Inc./

In the news release, "Forest Laboratories Revises Research and Development Spending Projection to Account for Upfront Payments for Two Recent In-Licensing Transactions" issued today, Feb. 15, by...

Holding(s) in Company

RNS Number:3979H Firth Rixson PLC 12 February 2003 Firth Rixson plc ("the Company") Firth Rixson plc was advised on 11 February 2003 that Deutsche Bank AG and its subsidiary companies no...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

FRX - Frequently Asked Questions (FAQ)

What is the current share price?
The current share price of is 0,45p
What is the 1 year trading range for share price?
has traded in the range of 0,00p to 0,00p during the past year

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
GENIGenincode Plc
6,75p
(110,94%)
9,24M
MFAIMindflair Plc
1,275p
(21,43%)
32,6M
WJGWatkin Jones Plc
23,70p
(19,46%)
4,04M
SYMESupply@me Capital Plc
0,0034p
(15,25%)
66,77M
AIEAAirea Plc
22,50p
(12,50%)
61,47k
MILAMila Resources Plc
0,175p
(-22,22%)
302,16k
QBTQuantum Blockchain Technologies Plc
1,225p
(-22,22%)
79,26M
REVBRevolution Beauty Group Plc
11,30p
(-19,97%)
3,17M
PPSProton Motor Power Systems Plc
0,245p
(-18,33%)
176,75k
TIRTiger Royalties And Investments Plc
0,14p
(-12,50%)
9,21M
NTVONativo Resources Plc
0,0021p
(5,00%)
182,64M
TRPTower Resources Plc
0,0285p
(-3,39%)
163,9M
RRRRed Rock Resources Plc
0,0575p
(-4,17%)
115,28M
QBTQuantum Blockchain Technologies Plc
1,225p
(-22,22%)
79,26M
SYMESupply@me Capital Plc
0,0034p
(15,25%)
66,77M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock